Skip to main content
logo
Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
5.80
-0.05 (-0.85%)
Oct 19, 2026, 12:10 PM EDT - Market open

Artiva Biotherapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-90.82-83.87-65.37-28.72-58.79-71.83
Depreciation & Amortization
2.692.62.432.271.160.25
Other Amortization
----4.08-
Loss (Gain) From Sale of Investments
-0.96-1.88-2.34-0.46--
Stock-Based Compensation
6.686.826.987.056.584.31
Other Operating Activities
--3.60.71-18.55
Change in Accounts Receivable
-0.19-1.03-0.51-0.06-0.47
Change in Accounts Payable
0.44-0.760.52-0.410.19-1.24
Change in Unearned Revenue
----26.53-2.4528.97
Change in Other Net Operating Assets
6.940.34-1.88-0.84-1.556.15
Operating Cash Flow
-75.23-76.75-55.03-47.43-50.83-15.3
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1.68-2.59-0.64-3.26-6.3-1.72
Investment in Securities
66.966-119.82-22.72--
Investing Cash Flow
65.2263.41-120.46-25.98-6.3-1.72

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--0.13-0.15---
Net Debt Issued (Repaid)
-0.11-0.13-0.15---
Issuance of Common Stock
300.070.14166.560.010.330.18
Repurchase of Common Stock
-0.4-0.23--0.01-0.01-
Other Financing Activities
-16.560.23-4.1824.39-1.59-2.03
Financing Cash Flow
2830.01162.2324.39-1.26152.75

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
272.99-13.33-13.27-49.01-58.39135.73

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-76.91-79.34-55.67-50.69-57.13-17.03
Free Cash Flow Growth
------
Free Cash Flow Margin
---22180.88%-151.34%-1158.55%-850.55%
Free Cash Flow Per Share
-2.72-3.25-4.95-63.14-74.51-24.83
Levered Free Cash Flow
-44.43-49.24-33.75-27.32-29.38-17.6
Unlevered Free Cash Flow
-44.43-49.24-33.75-27.32-29.38-17.6

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
---0.08--
Change in Working Capital
7.19-0.42-0.33-28.28-3.8733.41
SEC Filings: 10-K · 10-Q